DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fg4ns5/tuberculosis) has announced the addition of the "Tuberculosis - Pipeline Review, H2 2013" report to their offering.
Global Markets Direct's, 'Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Tuberculosis, complete with latest updates, and special features on late-stage and discontinued projects. Tuberculosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- A snapshot of the global therapeutic scenario for Tuberculosis.
- A review of the Tuberculosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Tuberculosis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Mentioned:
- AVI BioPharma Inc.
- Achillion Pharmaceuticals, Inc.
- Advinus Therapeutics Pvt. Ltd.
- Archivel Farma S.L.
- AstraZeneca PLC
- B&C Biopharm
- BT PHARMA
- Canopus BioPharma Incorporated
- Chimerix, Inc.
- Crucell N.V.
- Eli Lilly and Company
- Ensoltek Co., Ltd.
- EpiVax, Inc.
- GlaxoSmithKline Inc.
- GlaxoSmithKline plc
- Hollis-Eden Pharmaceuticals, Inc.
- ISA Pharmaceuticals B.V.
- Immune Network Research Ltd.
- ImmunoBiology Limited
- ImmunoVaccine Technologies Inc.
- Johnson & Johnson
- Lipotek Pty Ltd
- Medisyn Technologies, Inc.
- MicuRx Pharmaceuticals, Inc.
- Mondobiotech Holding AG
- NeED Pharma s.r.l.
- Okairos
- Pharminox Limited
- Piramal Healthcare Limited
- Pt. Bio Farma
- Recipharm AB
- Sanofi-Aventis
- Sequella, Inc.
- Snowdon Inc.
- Statens Serum Institut
- Summit Corporation plc
- TVAX Biomedical, LLC
- Transgene SA
- Vakzine Projekt Management GmbH
- Vertex Pharmaceuticals Incorporated
- Vichem Chemie Research Ltd.
For more information visit http://www.researchandmarkets.com/research/fg4ns5/tuberculosis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
